Gene · 84447
Papers1,633
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,633
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Functional rescue of a disease-linked ERAD pathway mutation via alternative splicing. | EMBO J | 2026 | 41862645 | PubTator, text mining | PubMed |
| Hijacking ERAD for targeted degradation of transmembrane proteins. | Cell | 2026 | 41861782 | PubTator, text mining | PubMed |
| SEL1L-HRD1 ERAD-autophagy interplay maintains mitochondrial homeostasis in brown adipocytes. | Proc Natl Acad Sci U S A | 2026 | 41843682 | PubTator, text mining | PubMed |
| Nrf3: an emerging player in cancer, inflammation, and cellular homeostasis. | Mol Biol Rep | 2026 | 41838283 | PubTator, text mining | PubMed |
| Endoplasmic reticulum stress in skeletal muscle dysfunction of type 2 diabetes: mechanisms and therapeutic implications. | Front Endocrinol (Lausanne) | 2026 | 41767393 | PubTator, text mining | PubMed |
| γ-Amino Carboxylic Acid Modification Enhances the Efficacy of Peptide Nucleic Acids Targeting miR-221-3p in Lung Cancer Cell Lines. | Curr Issues Mol Biol | 2026 | 41751459 | PubTator, text mining | PubMed |
| Metabolic Vulnerabilities as a Therapeutic Target in Breast Cancer. | Curr Oncol | 2026 | 41744893 | PubTator, text mining | PubMed |
| The Intersection of m6A Methylation and Immune Response in PCOS: A Bioinformatics Perspective. | Immun Inflamm Dis | 2026 | 41725222 | PubTator, text mining | PubMed |
| FOSL2 drives acute myeloid leukemogenesis through suppression of ERAD-induced proteostatic collapse. | Biochem Biophys Res Commun | 2026 | 41719883 | PubTator, text mining | PubMed |
| Dysregulated post‑translational modifications in granulosa cells drive ovarian dysfunction and potential infertility applications (Review). | Int J Mol Med | 2026 | 41716015 | PubTator, text mining | PubMed |
| Neuronal SEL1L-HRD1 ER-associated degradation is essential for motor function and survival in mice. | J Clin Invest | 2026 | 41712288 | PubTator, text mining | PubMed |
| Integrated Multiomics Elucidates Molecular Mechanisms of Bisphenol A in Exacerbating Crohn's Disease. | Mediators Inflamm | 2026 | 41695600 | PubTator, text mining | PubMed |
| SAPCD2 Drives Bladder Cancer Progression by Stabilizing TANK and Engaging a CREB-PLAGL2 Feedback Loop to Sustain MAPK Signaling. | Cancers (Basel) | 2026 | 41682005 | PubTator, text mining | PubMed |
| HSPA4 and SYVN1 positivity in osteoarthritis synovium as indicators of proteostasis dysfunction. | Clin Exp Rheumatol | 2026 | 41678149 | PubTator, text mining | PubMed |
| Identification of clofibric acid as a SYVN1 ligand for PROTAC development. | bioRxiv | 2026 | 41659405 | PubTator, text mining | PubMed |
| Regulation of ER-Resident Transcription Factor NFE2L1 in HEK293 Cells. | Biol Pharm Bull | 2026 | 41656087 | PubTator, text mining | PubMed |
| Functional integrity of the SEL1L-HRD1 complex is critical for endoplasmic reticulum-associated degradation and organismal viability. | Proc Natl Acad Sci U S A | 2026 | 41642983 | PubTator, text mining | PubMed |
| Ginsenoside Rb1 Targets the HRD1-STING Axis to Mitigate Cholesterol-Induced VSMC Senescence. | J Clin Lab Anal | 2026 | 41626813 | PubTator, text mining | PubMed |
| Proanthocyanidins enhance antitumor immunity by promoting ubiquitin-proteasomal PD-L1 degradation via stabilization of LKB1 and SYVN1. | J Clin Invest | 2026 | 41623165 | PubTator, text mining | PubMed |
| HRD1 negatively regulates autolysosome formation by inhibiting liquid-liquid phase separation of SNAP29. | Cell Rep | 2026 | 41615796 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84447/papers?page=2